Status: Recruiting
Efficacy and Safety of Oral Rifaximin in Patients With Active Microscopic Colitis
This is an open label study looking at rifaximin therapy for the treatment of microscopic (collagenous or lymphocytic) colitis.
Participants needed: 10
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Eugene F Yen, MDUpdated: Apr 15, 2021Locations: 1
Eligibility criteria
Collagenous colitis (CC) or lymphocytic colitis (LC) diagnosed on colon biopsies... [+3]